| 000 | 01560 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515063301.0 | ||
| 264 | 0 | _c20070426 | |
| 008 | 200704s 0 0 eng d | ||
| 022 | _a1648-9144 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVelickiene, Dzilda | |
| 245 | 0 | 0 |
_aPredicting outcome of treatment with radiotherapy in endocrine ophthalmopathy. _h[electronic resource] |
| 260 |
_bMedicina (Kaunas, Lithuania) _c2007 |
||
| 300 |
_a190-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAutoantibodies _xanalysis |
| 650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 |
_aExophthalmos _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGraves Disease _xblood |
| 650 | 0 | 4 |
_aGraves Ophthalmopathy _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 |
_aReceptors, Thyrotropin _ximmunology |
| 650 | 0 | 4 | _aSmoking |
| 650 | 0 | 4 |
_aThyrotropin _xblood |
| 650 | 0 | 4 |
_aThyroxine _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKazanavicius, Gintautas | |
| 700 | 1 | _aDanilevicius, Juozas | |
| 700 | 1 | _aJankauskiene, Jūrate | |
| 773 | 0 |
_tMedicina (Kaunas, Lithuania) _gvol. 43 _gno. 3 _gp. 190-8 |
|
| 999 |
_c16965172 _d16965172 |
||